Arkolith/Insider Trading/ADPT/Form 4

Benzeno Sharon

Chief Commercial Ofc Imm MedAdaptive Biotechnologies Corp (ADPT) · full profile →Form 4 · filed Jun 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.5M
Net Open-Market Flow
-$3.5M
Transactions
12
7 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)52K$8.12$419K376K
Jun 29, 2026Sell(S)155K$21.14$3.3M221K
Jun 29, 2026Option exercise(M)2K$12.14$22K275K
Jun 29, 2026Option exercise(M)25K$8.46$211K300K
Jun 29, 2026Option exercise(M)25K$3.99$100K324K
Jun 26, 2026Option exercise(M)11K$12.14$134K284K
Jun 26, 2026Sell(S)11K$21.00$232K273K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)2K—$00
Jun 29, 2026Option exercise(M)25K—$037K
Jun 29, 2026Option exercise(M)25K—$087K
Jun 29, 2026Option exercise(M)52K—$0113K
Jun 26, 2026Option exercise(M)11K—$02K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001780854-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML